Oncotelic Therapeutics, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Oncotelic Therapeutics, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $1.74 million for the year ending 2020.

  • This data is from Oncotelic Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on April 15, 2022.
  • XBRL data for this metric is available from 2020 to 2020 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: